Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Transaminases increased? 244 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Transaminases increased have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.3% of all adverse event reports for DOXORUBICIN.

244
Reports of Transaminases increased with DOXORUBICIN
0.3%
of all DOXORUBICIN reports
17
Deaths
94
Hospitalizations

How Dangerous Is Transaminases increased From DOXORUBICIN?

Of the 244 reports, 17 (7.0%) resulted in death, 94 (38.5%) required hospitalization, and 19 (7.8%) were considered life-threatening.

Is Transaminases increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 244 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Transaminases increased?

METHOTREXATE (1,236) ACETAMINOPHEN (929) ATORVASTATIN (472) RITUXIMAB (448) CYCLOPHOSPHAMIDE (401) PREDNISONE (362) ADALIMUMAB (340) PACLITAXEL (333) ROSUVASTATIN (324) CARBOPLATIN (319)

Which DOXORUBICIN Alternatives Have Lower Transaminases increased Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Transaminases increased Reports All Drugs Causing Transaminases increased DOXORUBICIN Demographics